SRR1499982
GTEX
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- GTEX
- cancer_type_detailed
- —
- subtype
- —
- cancer_type
- GTEX
- sex
- Male
GSVA pathway preview (50 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Top 10 elevated
- DNA_REPAIR+0.179
- KRAS_SIGNALING_DN+0.145
- MYC_TARGETS_V2+0.091
- MITOTIC_SPINDLE+0.026
- MYOGENESIS+0.016
- SPERMATOGENESIS+0.004
- OXIDATIVE_PHOSPHORYLATION-0.008
- APICAL_JUNCTION-0.053
- PI3K_AKT_MTOR_SIGNALING-0.066
- MYC_TARGETS_V1-0.073
Top 10 suppressed
- INTERFERON_ALPHA_RESPONSE-0.560
- TNFA_SIGNALING_VIA_NFKB-0.526
- INFLAMMATORY_RESPONSE-0.525
- INTERFERON_GAMMA_RESPONSE-0.496
- EPITHELIAL_MESENCHYMAL_TRANSITION-0.495
- TGF_BETA_SIGNALING-0.473
- IL6_JAK_STAT3_SIGNALING-0.469
- KRAS_SIGNALING_UP-0.461
- COAGULATION-0.448
- COMPLEMENT-0.448
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
10 twins match this tumor's tissue · 0 come from a different tissue of origin
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | SRR1400375 | GTEX | — | 0.988 |
| 2 | SRR1348770 | GTEX | — | 0.988 |
| 3 | SRR1464305 | GTEX | — | 0.987 |
| 4 | SRR1419675 | GTEX | — | 0.987 |
| 5 | SRR807657 | GTEX | — | 0.985 |
| 6 | SRR1434803 | GTEX | — | 0.984 |
| 7 | SRR1441200 | GTEX | — | 0.983 |
| 8 | SRR1441224 | GTEX | — | 0.983 |
| 9 | SRR1415215 | GTEX | — | 0.983 |
| 10 | SRR1440119 | GTEX | — | 0.983 |
Per-pathway drug coverage
For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.
0 of 6 elevated pathways have at least one drug that meaningfully reverses them.
| Pathway (elevated) | tumor score | Best drug | reversal magnitude |
|---|---|---|---|
| DNA_REPAIR | 0.179 | Idelalisib | — uncovered |
| KRAS_SIGNALING_DN | 0.145 | Remibrutinib | — uncovered |
| MYC_TARGETS_V2 | 0.091 | Idelalisib | — uncovered |
| MITOTIC_SPINDLE | 0.026 | Inavolisib | — uncovered |
| MYOGENESIS | 0.016 | Inavolisib | — uncovered |
| SPERMATOGENESIS | 0.004 | Inavolisib | — uncovered |